Sandbox:Mydah: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(206 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__  
__NOTOC__  
{{AE}} {{MSJ}}
{{AE}} {{MSJ}}
==[Patients on Hemodialysis before the pandemic]==
==Dysentery in adults resident survival guide==
===Overview===
===Overview===
The Covid-19 infection has high mortality among dialysis patients as compared to normal individuals. One of the factors for increased mortality for dialysis patients as compared to the general population due to COVID-19 infection is the increased age of the patients. Adequate measures should be taken to prevent the spread of COVID 19 infection in dialysis patients.
[[Dysentery]] is described as [[blood]] with [[Human feces|stools]]. It occurs due to inflammatory reaction causing damage to the [[Gastrointestinal tract|intestinal tract]]. The patient also has a [[fever]], abdominal cramping, discomfort, increased [[Intestine|bowel]] movements, fecal urgency, and [[tenesmus]]. The underlying cause is mostly an infection due to [[bacteria]]. The main aim of the [[physician]] is to assess the severity of gastrointestinal symptoms, [[dehydration]], and [[hypovolemia]]. In [[patient|patients]] with severe symptoms, prompt investigations, and treatment should be carried out to reduce morbidity. This section provides a short and straight to the point overview of the [[dysentery]] in adults.
===Pathophysiology===
 
Patients on hemodialysis have a mild clinical course of COVID 19 infection. It could be due to multiple reasons.
===Causes===
*Patients with chronic kidney disease or end-stage renal disease have low immunity. The low immunity results in low-intensity cytokine storm in response to viral antigens. The patients on maintenance hemodialysis rarely present with a full-blown clinical picture of pneumonia.<ref name="pmid32434211">{{cite journal| author=Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z | display-authors=etal| title=Viral and host factors related to the clinical outcome of COVID-19. | journal=Nature | year= 2020 | volume= | issue= | pages= | pmid=32434211 | doi=10.1038/s41586-020-2355-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32434211 }} </ref>
====Life-threatening Causes====
*Hypercoagulation plays an important role in aggravating the disease. Hypercoagulation initiates the coagulation cascade resulting in disseminated intravascular coagulation (DIC). DIC results in organ dysfunction and high mortality in COVID 19 infection. Anticoagulants administered during hemodialysis inhibit coagulation cascade preventing hypercoagulation and DIC.<ref name="pmid32073213">{{cite journal| author=Tang N, Li D, Wang X, Sun Z| title=Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. | journal=J Thromb Haemost | year= 2020 | volume= 18 | issue= 4 | pages= 844-847 | pmid=32073213 | doi=10.1111/jth.14768 | pmc=7166509 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32073213 }} </ref>
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
*In a study done at a hemodialysis center at Renmin Hospital in Wuhan, 37 out of a total of 230 patients were infected with covid 19 infections in one month. Four members of the health care staff were also infected. The peripheral blood examination of the covid 19 infected hemodialysis patients had reduced levels of killer T cells, helper T cells, Natural killer cells, and lower level of inflammatory cytokines as compared to non-dialysis infected patients.<ref name="pmid02.24.20027201">{{cite journal| author=Bose KS, Sarma RH| title=Delineation of the intimate details of the backbone conformation of pyridine nucleotide coenzymes in aqueous solution. | journal=Biochem Biophys Res Commun | year= 1975 | volume= 66 | issue= 4 | pages= 1173-9 | pmid=02.24.20027201 | doi=10.1016/0006-291x(75)90482-9 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2 }} </ref>
 
===Epidemiology and Demographics===
*Does not include any known cause
*Patients on maintenance hemodialysis and end-stage kidney disease have low immunity and multiple co-morbidities. They are at an increased risk of contracting the covid-19 infection.  A case series of 5,700 patients with covid-19 infection was done in 12 hospitals under the Northwell Health system in New York. It showed a prevalence of 5% chronic kidney disease and 3.5% end-stage renal disease in hospitalized covid-19 patients.<ref name="pmid32320003">{{cite journal| author=Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW | display-authors=etal| title=Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. | journal=JAMA | year= 2020 | volume= | issue= | pages= | pmid=32320003 | doi=10.1001/jama.2020.6775 | pmc=7177629 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32320003 }} </ref>
 
* A research study done in Japan showed a higher mortality 16.2% (16/99) in dialysis patients as compared to the general population 5.3% (874/16,532). The average age of patients on dialysis was 70 to 90 years while of the general population was 20 to 60 years.<ref name="pmid32506762">{{cite journal| author=Kikuchi K, Nangaku M, Ryuzaki M, Yamakawa T, Hanafusa N, Sakai K | display-authors=etal| title=COVID-19 in dialysis patients in Japan: Current status and guidance on preventive measures. | journal=Ther Apher Dial | year= 2020 | volume= | issue= | pages= | pmid=32506762 | doi=10.1111/1744-9987.13531 | pmc=7301044 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32506762 }} </ref>
====Common Causes====
*A study was done in 208 acute care hospitals in the UK. The total patients studied were 20,133. It showed chronic kidney disease was one of the most common co-morbidity in hospitalized covid-19 patients present in 16% of patients.<ref name="pmid32444460">{{cite journal| author=Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L | display-authors=etal| title=Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. | journal=BMJ | year= 2020 | volume= 369 | issue= | pages= m1985 | pmid=32444460 | doi=10.1136/bmj.m1985 | pmc=7243036 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32444460 }} </ref>
*[[Shigellosis]]<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718 }} </ref>
*Clinical research was done by Alberici et al. at four outpatient dialysis facilities in Italy showed high overall mortality of 29% in dialysis patients.<ref name="pmid32437768">{{cite journal| author=Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A | display-authors=etal| title=A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. | journal=Kidney Int | year= 2020 | volume= 98 | issue= 1 | pages= 20-26 | pmid=32437768 | doi=10.1016/j.kint.2020.04.030 | pmc=7206428 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32437768 }} </ref>
*[[Escherichia coli enteritis|Shiga toxin-producing E. coli]] (STEC) (eg, E. coli O157:H7) infection
*[[Amoebiasis|Amebic dysentery]] caused by [[Entamoeba histolytica]]<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718 }} </ref>
*[[Salmonella]] infection
*[[Campylobacter]] infection<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718 }} </ref>
*Enteric viruses (eg, [[cytomegalovirus]] [CMV] or [[adenovirus]])<ref name="pmid29053792">{{cite journal| author=Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K | display-authors=etal| title=2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. | journal=Clin Infect Dis | year= 2017 | volume= 65 | issue= 12 | pages= e45-e80 | pmid=29053792 | doi=10.1093/cid/cix669 | pmc=5850553 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29053792 }} </ref>
*[[Inflammatory bowel disease]]
*[[Ischemic colitis]]
 
===Evaluation===
Shown below is an algorithm summarizing the diagnosis of [[dysentery]] according to the American College of Gastroenterology guidelines.<ref name="pmid29053792">{{cite journal| author=Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K | display-authors=etal| title=2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. | journal=Clin Infect Dis | year= 2017 | volume= 65 | issue= 12 | pages= e45-e80 | pmid=29053792 | doi=10.1093/cid/cix669 | pmc=5850553 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29053792 }} </ref><ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref><ref name="pmid14702426">{{cite journal| author=Thielman NM, Guerrant RL| title=Clinical practice. Acute infectious diarrhea. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 1 | pages= 38-47 | pmid=14702426 | doi=10.1056/NEJMcp031534 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14702426 }} </ref><ref name="pmid12818275">{{cite journal| author=Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D | display-authors=etal| title=Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. | journal=Am J Gastroenterol | year= 2003 | volume= 98 | issue= 6 | pages= 1309-14 | pmid=12818275 | doi=10.1111/j.1572-0241.2003.07458.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12818275 }} </ref>
{{Family tree/start}}
{{Family tree | | | | A01 | | | |A01= <div style="float: center; text-align: left;">Characterize the symptoms:
* Duration of [[diarrhea]]
* Frequency and consistency of [[Human feces|stools]]
* Presence of [[mucus]] and [[blood]] in the [[Human feces|stools]] }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | B01 | | | |B01= <div style="float: center; text-align: left;">To evaluate cause ask the following questions:
* Food history
* Occupational exposure (e.g. daycare center, poultry farm)
* Exposure to animals (pets, poultry, zoo, turtles)
* Recent travel to endemic areas
* Medication history (use of [[proton pump inhibitor]] increase susceptibility to [[infection]] with [[Shigella]]) }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | C01 | | | |C01= <div style="float: center; text-align: left;">Does the patient have any of the following clinical signs or history?
* Old age (more than 70 years)
* Presence of co-morbidities (advance [[heart disease]], severe immunocompromised state)
* [[Fever]] (>101.3 degrees Fahrenheit)
* Presence of severe symptoms
* Need for hospitalization
* Signs of [[dehydration]] (dry mucous membranes, sunken [[Eye|eyes]], decreased [[skin]] turgor, [[orthostatic hypotension]], [[oliguria]], dark-colored [[urine]], and [[Somnolence|drowsiness]] )
abdominal tenderness on [[palpation]], [[rebound tenderness]], [[abdominal distention]], and abdominal rigidity. }}
{{Family tree | |,|-|-|^|-|-|-|-|.| | }}
{{Family tree | D01 | | | | | | D02 |D01= Yes |D02= No}}
{{Family tree | |!| | | | | | | |!| | }}
{{Family tree | E01 | | | | | | E02 |E01= <div style="float: center; text-align: left;">Perform the following [[Human feces|stool]] tests:
* Bacterial culture for [[Salmonella]], [[Shigella]], and [[Campylobacter]].
* Test for [[Shigella]] toxin and [[Escherichia coli|E. coli]] O157: H7
* Test for fecal [[leukocytes]] and [[lactoferrin]]. |E02= <div style="float: center; text-align: left;">Does the patient have any of the following:
* Clinical signs suggestive of [[inflammatory bowel disease]]
* Symptoms present for more than a week despite conservative management
* The patient is a health care worker or food handler (which can be a potential health hazard) }}
{{Family tree | |!| | | | | |,|-|^|-|.| }}
{{Family tree | F01 | | | | |F02| |F03| |F01= Is the fecal [[leukocytes]] or [[lactoferrin]] test positive? |F02= Yes |F03= No }}
{{Family tree |,|-|^|-|.| | | |!| | | |!| }}
{{Family tree |G01| |G02| |G03| |G04| G01=Yes |G02= No |G03=
* Perform routine [[Human feces|stool]] culture.
* Specific tests should be performed depending upon the patient’s history. |G04= No need to perform [[Human feces|Stool]] culture and additional tests. }}
{{Family tree |!| | | |!| | | }}
{{Family tree |F01| |F02| |F01= Test for [[Entamoeba histolytica]] |F02= [[Amoebiasis|Amebic dysentery]] highly unlikely. Look for other causative agents. }}
 
===Treatment===
===Treatment===
====Measures to prevent COVID 19 infection in hemodialysis patients====
Shown below is an algorithm summarizing the treatment of [[dysentery]] according to the Infectious Diseases Society of America clinical practice guidelines.<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref><ref name="pmid11100619">{{cite journal| author=Victora CG, Bryce J, Fontaine O, Monasch R| title=Reducing deaths from diarrhoea through oral rehydration therapy. | journal=Bull World Health Organ | year= 2000 | volume= 78 | issue= 10 | pages= 1246-55 | pmid=11100619 | doi= | pmc=2560623 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11100619  }} </ref><ref name="pmid20687081">{{cite journal| author=Christopher PR, David KV, John SM, Sankarapandian V| title=Antibiotic therapy for Shigella dysentery. | journal=Cochrane Database Syst Rev | year= 2010 | volume= | issue= 8 | pages= CD006784 | pmid=20687081 | doi=10.1002/14651858.CD006784.pub4 | pmc=6532574 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20687081 }} </ref>
Strict measures should be taken to prevent covid 19 infections in hemodialysis patients and health care workers. The measures include:
{{familytree/start }}
=====Screening of the patients=====
{{familytree | | | | | | | | A01 |A01= <div style="float: center; text-align: left;">Characterize the symptoms of the [[patient]]:
*Appropriate screening of patients should be done before dialysis. The best approach is to call patients and inquire about covid 19 symptoms.  
* Presence of severe [[diarrhea]] along with systemic symptoms.
*Patients reporting illness or covid 19 symptoms should be placed in the screening area. Hand sanitizers and face masks should be provided to patients.  
* Two or more clinical signs for [[dehydration]] (i.e. Sunken [[Eye|eyes]], dry [[mucous membrane]], reduced [[skin]] turgor, increased [[thirst]] ). }}
*A triage protocol should be instituted in dialysis facilities to take patients to testing clinics, particular dialysis facilities, and hospitals.<ref name="pmid32249840">{{cite journal| author=Ikizler TA, Kliger AS| title=Minimizing the risk of COVID-19 among patients on dialysis. | journal=Nat Rev Nephrol | year= 2020 | volume= 16 | issue= 6 | pages= 311-313 | pmid=32249840 | doi=10.1038/s41581-020-0280-y | pmc=7132217 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32249840 }} </ref>
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
=====Managing patients with suspected illness=====
{{familytree | | | B01 | | | | | | | | B02 | | |B01= Yes |B02= No }}
*If there are adequate resources in the hospital, patients should have dialysis at a specific shift, or a separate isolation dialysis ward should be made.  
{{familytree | | | |!| | | | | | | | | |!| | | }}
*Patients should be instructed to wear masks and cover mouth and nose while coughing and sneezing. This will reduce air droplet transmission of the virus.
{{familytree | | | C01 | | | | | | | | C02 | | |C01= <div style="float: left; text-align: left;">
*Suspected covid 19 patients should have at least 6 feet (2 meters) apart from each other in all directions.  
* [[Fluid replacement]] therapy.
=====Personnel protective equipment=====
* Empirical [[Antibiotic|antibiotics]] therapy.
*A selected group of healthcare personnel should be assigned for suspected covid 19 patients. Personal protective equipment should be given to patients and healthcare personnel.  
* The drug of choice is [[Quinolone|fluoroquinolones]] (500mg [[Levofloxacin (oral)]] once daily for 3 days).  If the symptoms do not improve in a few days, the patient should be switched to either [[azithromycin (oral)]] or [[cephalosporin]].  
*Healthcare workers should follow droplet and contact precautions. The workers should wear masks, gowns, goggles, shields, and gloves. Surgical face masks and N95 masks can be used. <ref name="pmid32198130">{{cite journal| author=Kliger AS, Silberzweig J| title=Mitigating Risk of COVID-19 in Dialysis Facilities. | journal=Clin J Am Soc Nephrol | year= 2020 | volume= 15 | issue= 5 | pages= 707-709 | pmid=32198130 | doi=10.2215/CJN.03340320 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32198130 }} </ref>
* Bismuth sulphate and [[loperamide]] to relieve abdominal cramps and discomfort. |C02= <div style="float: left; text-align: left;">
*Eyeshields and goggles can be used to prevent droplet spread via eyes.
* Oral [[fluid replacement]] therapy. Give [[Oral rehydration therapy|ORS]] solution for every [[Intestine|bowel]] movement. Approximately 2 liters of [[Oral rehydration therapy|ORS]] solution is given to the [[patient]].
=====Disinfection=====
* Antimicrobial therapy should be initiated on the basis of [[Human feces|stool]] culture results.
Disinfecting personnel should also wear personal protective equipment while disinfecting the dialysis surface. The dialysis machine, chair, dialysis surface station including BP cuff, stethoscope, the chairside stand should be cleaned with disinfecting wipes and allowed to be air dry.<ref name="pmid32198130">{{cite journal| author=Kliger AS, Silberzweig J| title=Mitigating Risk of COVID-19 in Dialysis Facilities. | journal=Clin J Am Soc Nephrol | year= 2020 | volume= 15 | issue= 5 | pages= 707-709 | pmid=32198130 | doi=10.2215/CJN.03340320 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32198130 }} </ref>
* Bismuth sulphate and [[loperamide]] can be given to relieve abdominal symptoms.
=====Optimum utilization of resources=====
* Reassess hydration status after every 6 hours. }}
*As pandemic will be for a long duration, hence resources should be utilized optimally. The gown should ideally be worn by both the health care workers and the patients.
{{familytree | | | |!| | | | | | | | }}
*If there are a limited number of gowns, then health care workers should wear it at the time of initiating and terminating dialysis, manipulating catheters and access sites, disinfecting dialysis station, and assisting to and from the dialysis station.  
{{familytree | | | D01 | | | | | | |D01= Assess [[patient]] for symptoms of [[hypovolemia]] (i.e. [[altered mental status]] with [[lethargy]] and [[unconsciousness]], weak [[Pulse|pulses]] , and inability to drink) }}
*The goggles and eye shields can be reused after proper disinfection procedure. The eye shields and face masks should be used for an extended time period.
{{familytree | |,|-|^|.| | | | }}
*A track of the personal protective equipment stock should be made.
{{familytree | D01 | | D02 | |D01= Yes |D02= No }}
=====Work labor Management=====
{{familytree | |!| | | |!| | | }}
*The healthcare workers are at risk for infection with covid-19 due to exposure. The exposure of health care workers can be minimized by working in shifts.
{{familytree | E01 | | E02 | |E01= <div style="float: left; text-align: left;">Patient has severe [[hypovolemia]].
*In this pandemic, the health care workers can become sick and shortage of health care staff can arise. To encounter it a back up list should be created to fill up the positions. Training courses should be conducted for the health care staff.  
* Give [[Intravenous therapy|parenteral]] [[fluid replacement]] with 5 % dextrose or [[Saline (medicine)|normal saline]] solution.
* Give rapid infusion initially and then slow infusion.
* The aim is to give 200 ml/kg in 24 hours with 100ml/kg in the first 4 hours of infusion.
* Reassess [[Hemodynamics|hemodynamic]] and hydration status of the [[patient]] after 6 hours. |E02= <div style="float: left; text-align: left;"> [[Patient]] has mild [[hypovolemia]].
* Give oral [[fluid replacement]] therapy.
* 2.2 to 4 liters of [[Oral rehydration therapy|ORS]] is given in the first 4 hours.
* Reassess [[Hemodynamics|hemodynamic]] and hydration status of the [[patient]] after 6 hours. }}
{{familytree/end}}
 
===Do's===
* Important clues regarding the etiology of dysentery can be narrowed down while taking history. If the patient has dysentery more than 16 hours after having an outdoor food consider [[Enterotoxigenic Escherichia coli|Enterotoxigenic ''E.coli'']]. There is an increased risk of acquiring the [[''Salmonella'']] infection in individuals exposed to turtles and poultry. People working in daycare have an increased risk of infection with enteric [[Virus|viruses]] and [[''Shigella'']].<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718 }} </ref>  
* Physicians can take a rectal swab in patients in whom stool samples cannot be obtained and immediate diagnosis is required.<ref name="pmid30944186">{{cite journal| author=Jean S, Yarbrough ML, Anderson NW, Burnham CA| title=Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens. | journal=J Clin Microbiol | year= 2019 | volume= 57 | issue= 6 | pages= | pmid=30944186 | doi=10.1128/JCM.02077-18 | pmc=6535583 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30944186  }} </ref> Though the rectal swab has less sensitivity than [[Human feces|stool]] culture in identifying the causative agent.<ref name="pmid30315956">{{cite journal| author=Kotar T, Pirš M, Steyer A, Cerar T, Šoba B, Skvarc M | display-authors=etal| title=Evaluation of rectal swab use for the determination of enteric pathogens: a prospective study of diarrhoea in adults. | journal=Clin Microbiol Infect | year= 2019 | volume= 25 | issue= 6 | pages= 733-738 | pmid=30315956 | doi=10.1016/j.cmi.2018.09.026 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30315956 }} </ref>
* If the clinician is suspecting a particular [[bacteria]], it should be mentioned while ordering the test. Certain [[bacteria]] require special culture media to grow and methods to be visualized. [[''Campylobacter jejuni'']] grows on the specific ‘CAMP’ agar plates at a particular temperature and environmental conditions. If infection with [[''Yersinia'']] is suspected, it should be specified as it is commonly overlooked.<ref name="pmid4014291">{{cite journal| author=Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH| title=Evaluation and diagnosis of acute infectious diarrhea. | journal=Am J Med | year= 1985 | volume= 78 | issue= 6B | pages= 91-8 | pmid=4014291 | doi=10.1016/0002-9343(85)90370-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4014291  }} </ref>
* Physicians need to monitor the patients for the complications of the infection with certain [[bacteria]]. [[Bacteremia]] and [[reactive arthritis]] can occur with infection with non- typhoidal [[''Salmonella'']] and [[''Shigella'']].<ref name="pmid16621698">{{cite journal| author=Rodríguez M, de Diego I, Martínez N, Rosario Rodicio M, Carmen Mendoza M| title=Nontyphoidal Salmonella causing focal infections in patients admitted at a Spanish general hospital during an 11-year period (1991-2001). | journal=Int J Med Microbiol | year= 2006 | volume= 296 | issue= 4-5 | pages= 211-22 | pmid=16621698 | doi=10.1016/j.ijmm.2006.01.068 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16621698  }} </ref> The [[hemolytic-uremic syndrome]] can occur due to E 0157:H7 or [[''Shigella'']]. A neurological complication [[Guillain-Barré syndrome]] can occur with [[''Campylobacter'']] infection.
===Don'ts===
* The empirical antimicrobial [[treatment]] for [[dysentery]] does not include [[treatment]] for [[Entamoeba histolytica|''E. histolytica'']]. [[Metronidazole]] (500mg thrice daily for 7 to days) should be administered to [[patient|patients]] only when trophozoites or cysts are visualized under a [[microscope]] in the [[Human feces|stool]] sample.<ref name="pmid590600">{{cite journal| author=Misra NP, Gupta RC| title=A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis. | journal=J Int Med Res | year= 1977 | volume= 5 | issue= 6 | pages= 434-7 | pmid=590600 | doi=10.1177/030006057300100209 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=590600  }} </ref>
* A complete metabolic profile is not routinely performed in [[patient|patients]] with [[dysentery]]. [[Serum]] electrolytes and [[glucose]] levels should only be measured in [[patient|patients]] who present with complications (i.e. [[altered mental status]], [[Seizure|seizures]], [[anuria]], [[oliguria]], and [[ileus]] ).
 
==References==
==References==
{{Reflist}}
{{Reflist}}

Latest revision as of 22:10, 26 August 2020


Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]

Dysentery in adults resident survival guide

Overview

Dysentery is described as blood with stools. It occurs due to inflammatory reaction causing damage to the intestinal tract. The patient also has a fever, abdominal cramping, discomfort, increased bowel movements, fecal urgency, and tenesmus. The underlying cause is mostly an infection due to bacteria. The main aim of the physician is to assess the severity of gastrointestinal symptoms, dehydration, and hypovolemia. In patients with severe symptoms, prompt investigations, and treatment should be carried out to reduce morbidity. This section provides a short and straight to the point overview of the dysentery in adults.

Causes

Life-threatening Causes

Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.

  • Does not include any known cause

Common Causes

Evaluation

Shown below is an algorithm summarizing the diagnosis of dysentery according to the American College of Gastroenterology guidelines.[2][1][3][4]

Treatment

Shown below is an algorithm summarizing the treatment of dysentery according to the Infectious Diseases Society of America clinical practice guidelines.[1][5][6]

 
 
 
Characterize the symptoms:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To evaluate cause ask the following questions:
  • Food history
  • Occupational exposure (e.g. daycare center, poultry farm)
  • Exposure to animals (pets, poultry, zoo, turtles)
  • Recent travel to endemic areas
  • Medication history (use of proton pump inhibitor increase susceptibility to infection with Shigella)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following clinical signs or history? abdominal tenderness on palpation, rebound tenderness, abdominal distention, and abdominal rigidity.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform the following stool tests:
 
 
 
 
 
Does the patient have any of the following:
  • Clinical signs suggestive of inflammatory bowel disease
  • Symptoms present for more than a week despite conservative management
  • The patient is a health care worker or food handler (which can be a potential health hazard)
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Is the fecal leukocytes or lactoferrin test positive?
     
     
     
     
    Yes
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    No
     
    * Perform routine stool culture.
    • Specific tests should be performed depending upon the patient’s history.
     
    No need to perform Stool culture and additional tests.
     
     
     
     
     
     
     
     
     
     
    Test for Entamoeba histolytica
     
    Amebic dysentery highly unlikely. Look for other causative agents.
     
     
     
     
     
     
     
     
    Characterize the symptoms of the patient:
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
     
     
     
     
     
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
  • Oral fluid replacement therapy. Give ORS solution for every bowel movement. Approximately 2 liters of ORS solution is given to the patient.
  • Antimicrobial therapy should be initiated on the basis of stool culture results.
  • Bismuth sulphate and loperamide can be given to relieve abdominal symptoms.
  • Reassess hydration status after every 6 hours.
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Assess patient for symptoms of hypovolemia (i.e. altered mental status with lethargy and unconsciousness, weak pulses , and inability to drink)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
    Patient has severe hypovolemia.
    • Give parenteral fluid replacement with 5 % dextrose or normal saline solution.
    • Give rapid infusion initially and then slow infusion.
    • The aim is to give 200 ml/kg in 24 hours with 100ml/kg in the first 4 hours of infusion.
    • Reassess hemodynamic and hydration status of the patient after 6 hours.
     
    Patient has mild hypovolemia.
  • Give oral fluid replacement therapy.
  • 2.2 to 4 liters of ORS is given in the first 4 hours.
  • Reassess hemodynamic and hydration status of the patient after 6 hours.
  •  

    Do's

    • Important clues regarding the etiology of dysentery can be narrowed down while taking history. If the patient has dysentery more than 16 hours after having an outdoor food consider Enterotoxigenic E.coli. There is an increased risk of acquiring the ''Salmonella'' infection in individuals exposed to turtles and poultry. People working in daycare have an increased risk of infection with enteric viruses and ''Shigella''.[1]
    • Physicians can take a rectal swab in patients in whom stool samples cannot be obtained and immediate diagnosis is required.[7] Though the rectal swab has less sensitivity than stool culture in identifying the causative agent.[8]
    • If the clinician is suspecting a particular bacteria, it should be mentioned while ordering the test. Certain bacteria require special culture media to grow and methods to be visualized. ''Campylobacter jejuni'' grows on the specific ‘CAMP’ agar plates at a particular temperature and environmental conditions. If infection with ''Yersinia'' is suspected, it should be specified as it is commonly overlooked.[9]
    • Physicians need to monitor the patients for the complications of the infection with certain bacteria. Bacteremia and reactive arthritis can occur with infection with non- typhoidal ''Salmonella'' and ''Shigella''.[10] The hemolytic-uremic syndrome can occur due to E 0157:H7 or ''Shigella''. A neurological complication Guillain-Barré syndrome can occur with ''Campylobacter'' infection.

    Don'ts

    References

    1. 1.0 1.1 1.2 1.3 1.4 1.5 Riddle MS, DuPont HL, Connor BA (2016). "ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults". Am J Gastroenterol. 111 (5): 602–22. doi:10.1038/ajg.2016.126. PMID 27068718.
    2. 2.0 2.1 Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K; et al. (2017). "2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea". Clin Infect Dis. 65 (12): e45–e80. doi:10.1093/cid/cix669. PMC 5850553. PMID 29053792.
    3. Thielman NM, Guerrant RL (2004). "Clinical practice. Acute infectious diarrhea". N Engl J Med. 350 (1): 38–47. doi:10.1056/NEJMcp031534. PMID 14702426.
    4. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D; et al. (2003). "Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation". Am J Gastroenterol. 98 (6): 1309–14. doi:10.1111/j.1572-0241.2003.07458.x. PMID 12818275.
    5. Victora CG, Bryce J, Fontaine O, Monasch R (2000). "Reducing deaths from diarrhoea through oral rehydration therapy". Bull World Health Organ. 78 (10): 1246–55. PMC 2560623. PMID 11100619.
    6. Christopher PR, David KV, John SM, Sankarapandian V (2010). "Antibiotic therapy for Shigella dysentery". Cochrane Database Syst Rev (8): CD006784. doi:10.1002/14651858.CD006784.pub4. PMC 6532574 Check |pmc= value (help). PMID 20687081.
    7. Jean S, Yarbrough ML, Anderson NW, Burnham CA (2019). "Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens". J Clin Microbiol. 57 (6). doi:10.1128/JCM.02077-18. PMC 6535583 Check |pmc= value (help). PMID 30944186.
    8. Kotar T, Pirš M, Steyer A, Cerar T, Šoba B, Skvarc M; et al. (2019). "Evaluation of rectal swab use for the determination of enteric pathogens: a prospective study of diarrhoea in adults". Clin Microbiol Infect. 25 (6): 733–738. doi:10.1016/j.cmi.2018.09.026. PMID 30315956.
    9. Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH (1985). "Evaluation and diagnosis of acute infectious diarrhea". Am J Med. 78 (6B): 91–8. doi:10.1016/0002-9343(85)90370-5. PMID 4014291.
    10. Rodríguez M, de Diego I, Martínez N, Rosario Rodicio M, Carmen Mendoza M (2006). "Nontyphoidal Salmonella causing focal infections in patients admitted at a Spanish general hospital during an 11-year period (1991-2001)". Int J Med Microbiol. 296 (4–5): 211–22. doi:10.1016/j.ijmm.2006.01.068. PMID 16621698.
    11. Misra NP, Gupta RC (1977). "A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis". J Int Med Res. 5 (6): 434–7. doi:10.1177/030006057300100209. PMID 590600.